The groundbreaking therapy of this peptide represents a major advance in the handling of the condition. Distinct from existing therapies, tirzepatide targets dual pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatidepeptide240646.yomoblog.com/49398462/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment